The number of people with susceptibility test result for rifampicin in Philippines
Philippines: The number of people with susceptibility test result for rifampicin was 88.57 in 2021. ◆ Volatile
Latest (2021)
88.57
Change on year
up 4.3%
World rank
73rd
of 146 countries
All-time high
88.57
in 2021
All-time low
0.8782
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Philippines, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Philippines stood at 88.57. That is the highest value across all 5 years on record.
That represents a change of up 4.3% on the previous year and up 250.1% over five years.
Philippines ranks 73rd of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Philippines, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 25.3 | — |
| 2018 | 0.8782 | -96.5% |
| 2019 | 56.68 | +6353.9% |
| 2020 | 84.92 | +49.8% |
| 2021 | 88.57 | +4.3% |
Philippines compared with similar countries
- Philippines's 88.57 is below the median for upper middle income countries, which is 92.7, 96% of the median. (45 countries reporting)
- Philippines's 88.57 is below the median for East Asia & Pacific, which is 96.47, 92% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 27.62 | 0.8782 | 56.68 | 3 |
| 2020s | 86.74 | 84.92 | 88.57 | 2 |
Countries ranked near Philippines
More health data for Philippines
- Un projection of annual infant deaths, annual growth rate -1.24 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5317 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,456 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7,006 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 89 (2025)
- Population ages 00-04, female, annual growth rate -2.61 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.037 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.21 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Philippines?
- The number of people with susceptibility test result for rifampicin in Philippines was 88.57 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Philippines?
- The highest recorded value was 88.57 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Philippines?
- The lowest recorded value was 0.8782 in 2018.
- How does Philippines rank for the number of people with susceptibility test result for rifampicin?
- Philippines ranks 73rd out of 146 countries with data for 2021.
- Where does this Philippines data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).